Calculation
Total asset turnover | = | Revenues1 | ÷ | Total assets1 | |
---|---|---|---|---|---|
Dec 31, 2023 | 0.47 | = | 45,006) | ÷ | 95,159) |
Dec 31, 2022 | 0.48 | = | 46,159) | ÷ | 96,820) |
Dec 31, 2021 | 0.42 | = | 46,385) | ÷ | 109,314) |
Dec 31, 2020 | 0.36 | = | 42,518) | ÷ | 118,481) |
Dec 31, 2019 | 0.20 | = | 26,145) | ÷ | 129,944) |
Dec 31, 2018 | 0.64 | = | 22,561) | ÷ | 34,986) |
Dec 31, 2017 | 0.62 | = | 20,776) | ÷ | 33,551) |
Dec 31, 2016 | 0.58 | = | 19,427) | ÷ | 33,707) |
Dec 31, 2015 | 0.52 | = | 16,560) | ÷ | 31,748) |
Dec 31, 2014 | 0.47 | = | 15,879) | ÷ | 33,749) |
Dec 31, 2013 | 0.42 | = | 16,385) | ÷ | 38,592) |
Dec 31, 2012 | 0.49 | = | 17,621) | ÷ | 35,897) |
Dec 31, 2011 | 0.64 | = | 21,244) | ÷ | 32,970) |
Dec 31, 2010 | 0.63 | = | 19,484) | ÷ | 31,076) |
Dec 31, 2009 | 0.61 | = | 18,808) | ÷ | 31,008) |
Dec 31, 2008 | 0.70 | = | 20,597) | ÷ | 29,552) |
Dec 31, 2007 | 0.74 | = | 19,348) | ÷ | 26,172) |
Dec 31, 2006 | 0.70 | = | 17,914) | ÷ | 25,575) |
Dec 31, 2005 | 0.68 | = | 19,207) | ÷ | 28,138) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
Comparison to Competitors
Bristol-Myers Squibb Co. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2023 | 0.47 | 0.40 | 0.28 | 0.28 | 0.53 | 0.43 | 0.51 | 0.56 | 0.36 | 0.26 | 0.40 | 0.43 |
Dec 31, 2022 | 0.48 | 0.42 | 0.38 | 0.37 | 0.58 | 0.43 | 0.51 | 0.54 | 0.71 | 0.51 | 0.42 | 0.46 |
Dec 31, 2021 | 0.42 | 0.38 | 0.40 | 0.35 | 0.58 | 0.40 | 0.52 | 0.46 | 0.72 | 0.45 | 0.63 | 0.41 |
Dec 31, 2020 | 0.36 | 0.30 | 0.39 | 0.29 | 0.53 | 0.36 | 0.47 | 0.52 | 0.03 | 0.27 | 0.50 | 0.47 |
Dec 31, 2019 | 0.20 | 0.37 | 0.37 | 0.29 | 0.57 | 0.36 | 0.52 | 0.55 | 0.00 | 0.31 | 0.53 | 0.44 |
Dec 31, 2018 | 0.64 | 0.55 | 0.34 | 0.42 | 0.56 | 0.34 | 0.53 | 0.51 | 0.00 | 0.34 | 0.57 | 0.43 |
Dec 31, 2017 | 0.62 | 0.40 | 0.27 | 0.39 | 0.51 | 0.37 | 0.49 | 0.46 | — | 0.31 | 0.67 | 0.37 |
Dec 31, 2016 | 0.58 | 0.39 | 0.28 | 0.37 | 0.55 | 0.53 | 0.51 | 0.42 | — | 0.31 | 0.70 | 0.40 |
Dec 31, 2015 | 0.52 | 0.43 | 0.29 | 0.43 | 0.56 | 0.62 | 0.53 | 0.39 | — | 0.29 | 0.73 | 0.41 |
Dec 31, 2014 | 0.47 | 0.72 | 0.28 | 0.54 | 0.53 | 0.71 | 0.57 | 0.43 | — | 0.29 | 0.73 | 0.39 |
Dec 31, 2013 | 0.42 | 0.64 | 0.28 | 0.55 | 0.66 | 0.48 | 0.54 | 0.42 | — | 0.30 | 0.71 | 0.41 |
Dec 31, 2012 | 0.49 | 0.68 | 0.31 | 0.55 | 0.66 | 0.44 | 0.55 | 0.45 | — | 0.32 | 0.66 | 0.46 |
Dec 31, 2011 | 0.64 | — | 0.31 | 0.54 | 0.72 | 0.47 | 0.57 | 0.46 | — | 0.36 | 0.34 | 0.44 |
Dec 31, 2010 | 0.63 | — | 0.34 | 0.59 | 0.74 | 0.64 | 0.60 | 0.43 | — | 0.35 | 0.42 | 0.51 |
Dec 31, 2009 | 0.61 | — | 0.36 | 0.57 | 0.80 | 0.67 | 0.65 | 0.24 | — | 0.23 | 0.51 | 0.47 |
Dec 31, 2008 | 0.70 | — | 0.40 | 0.73 | 0.70 | 0.72 | 0.75 | 0.51 | — | 0.43 | 0.36 | 0.50 |
Dec 31, 2007 | 0.74 | — | 0.41 | 0.63 | 0.70 | 0.64 | 0.75 | 0.50 | — | 0.42 | 0.13 | 0.46 |
Dec 31, 2006 | 0.70 | — | 0.41 | 0.75 | 0.71 | 0.63 | 0.76 | 0.51 | — | 0.42 | 0.11 | 0.18 |
Dec 31, 2005 | 0.68 | — | 0.41 | 0.87 | 0.60 | 0.48 | 0.87 | 0.49 | — | 0.44 | 0.16 | 0.62 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Bristol-Myers Squibb Co., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
Bristol-Myers Squibb Co. | Pharmaceuticals, Biotechnology & Life Sciences | |
---|---|---|
Dec 31, 2023 | 0.47 | 0.40 |
Dec 31, 2022 | 0.48 | 0.48 |
Dec 31, 2021 | 0.42 | 0.45 |
Dec 31, 2020 | 0.36 | 0.38 |
Dec 31, 2019 | 0.20 | 0.39 |
Dec 31, 2018 | 0.64 | 0.45 |
Dec 31, 2017 | 0.62 | 0.40 |
Dec 31, 2016 | 0.58 | 0.41 |
Dec 31, 2015 | 0.52 | 0.42 |
Dec 31, 2014 | 0.47 | 0.45 |
Dec 31, 2013 | 0.42 | 0.43 |
Dec 31, 2012 | 0.49 | 0.45 |
Dec 31, 2011 | 0.64 | 0.46 |
Dec 31, 2010 | 0.63 | 0.47 |
Dec 31, 2009 | 0.61 | 0.39 |
Dec 31, 2008 | 0.70 | 0.57 |
Dec 31, 2007 | 0.74 | 0.56 |
Dec 31, 2006 | 0.70 | 0.54 |
Dec 31, 2005 | 0.68 | 0.57 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Bristol-Myers Squibb Co., total asset turnover, long-term trends, comparison to industry (health care)
Bristol-Myers Squibb Co. | Health Care | |
---|---|---|
Dec 31, 2023 | 0.47 | 0.80 |
Dec 31, 2022 | 0.48 | 0.81 |
Dec 31, 2021 | 0.42 | 0.76 |
Dec 31, 2020 | 0.36 | 0.70 |
Dec 31, 2019 | 0.20 | 0.71 |
Dec 31, 2018 | 0.64 | 0.67 |
Dec 31, 2017 | 0.62 | 0.68 |
Dec 31, 2016 | 0.58 | 0.70 |
Dec 31, 2015 | 0.52 | 0.67 |
Dec 31, 2014 | 0.47 | 0.72 |
Dec 31, 2013 | 0.42 | 0.69 |
Dec 31, 2012 | 0.49 | 0.69 |
Dec 31, 2011 | 0.64 | 0.70 |
Dec 31, 2010 | 0.63 | 0.69 |
Dec 31, 2009 | 0.61 | 0.64 |
Dec 31, 2008 | 0.70 | 0.81 |
Dec 31, 2007 | 0.74 | 0.77 |
Dec 31, 2006 | 0.70 | 0.74 |
Dec 31, 2005 | 0.68 | 0.70 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).